TP53 and prostate carcinoma: Here, we demonstrate that ID4, can promote p53-dependent apoptosis and senescence in prostate cancer cells by specifically modifying the acetylation of p53, which increases its transcriptional activity and promotes the expression of pro-apoptotic and cell cycle regulatory genes.